Cited by 6,670Bone Metabolism and DiseasesBone health and osteoporosis researchBone and Dental Protein Studies

The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.

Osteoclast differentiation and activation

Boyle, William J., Simonet, W. Scott, Lacey, David L.·2003·Nature

Open this paper in CoChat — free account

Abstract

Osteoclasts are specialized cells derived from the monocyte/macrophage haematopoietic lineage that develop and adhere to bone matrix, then secrete acid and lytic enzymes that degrade it in a specialized, extracellular compartment. Discovery of the RANK signalling pathway in the osteoclast has provided insight into the mechanisms of osteoclastogenesis and activation of bone resorption, and how hormonal signals impact bone structure and mass. Further study of this pathway is providing the molecular basis for developing therapeutics to treat osteoporosis and other diseases of bone loss.

Integrity signals

Registry

Crossref · 10.1038/nature01658

Cites

77 of 77 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Self-citation
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
Self-citation
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,224
Bone Resorption by Osteoclasts
Teitelbaum, S. L. (2000) · Science · doi:10.1126/science.289.5484.1504 · Cited by 3,962
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351
Self-citation
Induction and Activation of the Transcription Factor NFATc1 (NFAT2) Integrate RANKL Signaling in Terminal Differentiation of Osteoclasts
Takayanagi, H., Kim, S., Koga, T., Nishina, H., Isshiki, M., Yoshida, H., Saiura, A., Isobe, M., Yokochi, T., Inoue, J.-I., et al. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00369-6 · Cited by 2,701
Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.
Bucay, N., Sarosi, I., Dunstan, C. R., Morony, S., Tarpley, J., Capparelli, C., Scully, S., Tan, H. L., Xu, W., Lacey, D. L., et al. (1998) · Genes & Development · doi:10.1101/gad.12.9.1260 · Cited by 2,483
Self-citation
NF-κB in cancer: from innocent bystander to major culprit
Karin, M., Cao, Y., Greten, F. R., & Li, Z. (2002) · Nature reviews. Cancer · doi:10.1038/nrc780 · Cited by 2,476
A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.
Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D., & Galibert, L. (1997) · Nature · doi:10.1038/36593 · Cited by 2,290
Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand.
Kong, Y.-Y., Feige, U., Sarosi, I., Bolon, B., Tafuri, A., Morony, S., Capparelli, C., Li, J., Elliott, R., McCabe, S., et al. (1999) · Nature · doi:10.1038/46303 · Cited by 1,856
Self-citation

Show all 77 references

Sorted by citations

Items 501–600 of 1,034

CYR61 Regulates BMP-2-dependent Osteoblast Differentiation through the αvβ3 Integrin/Integrin-linked Kinase/ERK Pathway
Su, J.-L., Chiou, J., Tang, C.-H., Zhao, M., Tsai, C.-H., Chen, P.-S., Chang, Y.-W., Chien, M.-H., Peng, C.-Y., Hsiao, M., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.087122 · Cited by 121
Vitamin D endocrine system and osteoclasts
Takahashi, N., Udagawa, N., & Suda, T. (2014) · BoneKEy Reports · doi:10.1038/bonekey.2013.229 · Cited by 129
“Thus, ODF, OPGL, TRANCE and RANKL are different names for the same ligand, and OPG and OCIF are different names for the same decoy receptor.(38,39) According to the President’s Committee on Nomenclature (2000) of the American Society for Bone and Mineral Research, the terms ‘RANKL’ as the ligand, ‘RANK’ as the recepto…”
Background
Icariin protects against titanium particle-induced osteolysis and inflammatory response in a mouse calvarial model
Shao, H., Shen, J., Wang, M., Cui, J., Wang, Y., Zhu, S., Zhang, W., Yang, H., Xu, Y., & Geng, D. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.04.048 · Cited by 122
Metformin; an old antidiabetic drug with new potentials in bone disorders
Bahrambeigi, S., Yousefi, B., Rahimi, M., & Shafiei‐Irannejad, V. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.11.032 · Cited by 125
Molecular-Based Treatment Strategies for Osteoporosis: A Literature Review
Ukon, Y., Makino, T., Kodama, J., Tsukazaki, H., Tateiwa, D., Yoshikawa, H., & Kaito, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102557 · Cited by 121
“Osteoprotegerin (OPG), which is also produced by cells in the osteoblast lineage, is a soluble decoy receptor of RANKL that prevents binding of RANKL to RANK [11].”
Background
Ubiquitin chain cleavage: CYLD at work
Massoumi, R. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.02.007 · Cited by 122
Interferon‐β‐induced miR‐155 inhibits osteoclast differentiation by targeting SOCS1 and MITF
Zhang, J., Zhao, H., Chen, J., Xia, B., Jin, Y., Wei, W., Shen, J., & Huang, Y. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.06.047 · Cited by 122
Roles of the TRAF6 and Pellino E3 ligases in MyD88 and RANKL signaling
Strickson, S., Emmerich, C. H., Goh, E. T. H., Zhang, J., Kelsall, I. R., Macartney, T., Hastie, C. J., Knebel, A., Peggie, M. W., Marchesi, F., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1702367114 · Cited by 117
“RANKL, a TNF superfamily member, signals via its receptor RANK, which interacts directly with TRAF6 to initiate signaling (40, 41) by activating TAK1 (42, 43).”
Background
Bone cancer increases transient receptor potential vanilloid subfamily 1 expression within distinct subpopulations of dorsal root ganglion neurons
Niiyama, Y., Kawamata, T., Yamamoto, J., Omote, K., & Namiki, A. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.05.049 · Cited by 120
Differential cytokine expressions affect the severity of peri‐implant disease
Duarte, P. M., de Mendonça, A. C., Máximo, M. B. B., Santos, V. R., Bastos, M. F., & Nociti, F. H. (2009) · Clinical Oral Implants Research · doi:10.1111/j.1600-0501.2008.01680.x · Cited by 125
Transcriptional regulation of bone and joint remodeling by NFAT
Sitara, D., & Aliprantis, A. O. (2009) · Immunological Reviews · doi:10.1111/j.0105-2896.2009.00849.x · Cited by 120
“Osteoclasts are bone-resorbing multinucleated giant cells that differentiate from myeloid precursors in response to macrophage colony-stimulating factor (M-CSF) and receptor activator of NF-jB ligand (RANKL) (28).”
Background
Targeting myostatin/activin A protects against skeletal muscle and bone loss during spaceflight
Lee, S.-J., Lehar, A., Meir, J. U., Koch, C., Morgan, A., Warren, L. E., Rydzik, R., Youngstrom, D. W., Chandok, H., George, J., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2014716117 · Cited by 115
“Because TRAIL and RANKL are known to regulate osteoclast differentiation and survival (33 – 35), these findings suggest that increased RANK (tumor necrosis factor receptor superfamily member 11a) signaling may be involved in the regulation of bone growth and remodeling induced by ACVR2B/Fc.…”
Overexpression of Sirtuin 6 Suppresses Inflammatory Responses and Bone Destruction in Mice With Collagen‐Induced Arthritis
Lee, H., Ka, S., Lee, S., Lee, S., Park, J., & Park, B. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37963 · Cited by 119
The role of complement in trauma and fracture healing
Huber-Lang, M. S., Kovtun, A., & Ignatius, A. A. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.05.006 · Cited by 119
Osteoporosis remission via an anti-inflammaging effect by icariin activated autophagy
Bai, L., Liu, Y., Zhang, X., Chen, P., Hang, R., Xiao, Y., Wang, J., & Liu, C. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122125 · Cited by 124
Imbalance of osteoclastogenesis-regulating factors in patients with celiac disease.
Taranta, A., Fortunati, D., Longo, M., Rucci, N., Iacomino, E., Aliberti, F., Facciuto, E., Migliaccio, S., Bardella, M. T., Dubini, A., et al. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040319 · Cited by 118
“After 1 h, cultures were rinsed to remove nonadherent cells and thereafter were maintained for 7–21 days in medium containing 10% human serum from celiac patients or healthy donors in the presence of 25 ng/ml M-CSF, 100 nM recombinant human PTH(1-34)”
BackgroundMethodInfluential
Simvastatin, 3‐hydroxy‐3‐methylglutaryl coenzyme A reductase inhibitor, suppresses osteoclastogenesis induced by receptor activator of nuclear factor‐κB ligand through modulation of NF‐κB pathway
Ahn, K. S., Sethi, G., Chaturvedi, M. M., & Aggarwal, B. B. (2008) · International Journal of Cancer · doi:10.1002/ijc.23745 · Cited by 109
Denosumab: Anti-RANKL antibody
Miller, P. D. (2009) · Current Osteoporosis Reports · doi:10.1007/s11914-009-0004-5 · Cited by 125
“This process is regulated by systemic and local regulators of bone cell activity [3–5].”
Background
The clinical use of bone morphogenetic proteins revisited: a novel biocompatible carrier device OSTEOGROW for bone healing
Vukičević, S., Oppermann, H., Verbanac, D., Jankolija, M., Popek, I., Ćurak, J., Brkljačić, J. M., Pauk, M., Erjavec, I., Francetić, I., et al. (2013) · International Orthopaedics · doi:10.1007/s00264-013-2201-1 · Cited by 119
Artesunate attenuates LPS-induced osteoclastogenesis by suppressing TLR4/TRAF6 and PLCγ1-Ca2+-NFATc1 signaling pathway
Zeng, X., Yue-yang, Z., Yang, Q. Z., Wang, S., Zou, B., Tan, Y., Zou, M., Liu, S., & Li, X. (2019) · Acta Pharmacologica Sinica · doi:10.1038/s41401-019-0289-6 · Cited by 120
Type I collagen decorated nanoporous network on titanium implant surface promotes osseointegration through mediating immunomodulation, angiogenesis, and osteogenesis
Zhao, Y., Bai, L., Zhang, Y., Yao, R., Sun, Y., Hang, R., Chen, X., Wang, H., Yao, X., Xiao, Y., et al. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121684 · Cited by 121
Treatment of Hypercalcemia of Malignancy in Adults: An Endocrine Society Clinical Practice Guideline
Fuleihan, G. E., Clines, G. A., Hu, M. I.-N., Marcocci, C., Murad, M. H., Piggott, T., Poznak, C. H. V., Wu, J. Y., & Drake, M. T. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac621 · Cited by 118
Inflammatory Processes Affecting Bone Health and Repair
de Oliveira, H. T., Arnold, K. M., Oviedo, M., Westendorf, J. J., & Weaver, S. R. (2023) · Current Osteoporosis Reports · doi:10.1007/s11914-023-00824-4 · Cited by 135
“Osteoclasts are bone-resorbing cells that derive from the monocyte/ macrophage lineage following stimulation by M-CSF and RANKL [27, 28].”
Catalytic Activity of Human ADAM33
Zou, J., Zhu, F., Liu, J., Wang, W., Zhang, R., Garlisi, C. G., Liu, Y., Wang, S., Shah, H., Wan, Y., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309696200 · Cited by 121
Cell responses to bone morphogenetic proteins and peptides derived from them: Biomedical applications and limitations
Senta, H., Park, H., Bergeron, E., Drevelle, O., Fong, D. W. F., Leblanc, É., Cabana, F., Roux, S., Grenier, G., & Faucheux, N. (2009) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.05.006 · Cited by 117
“It is a secreted decoy receptor expressed by osteoblast/stromal cells, which recognizes RANKL, and in doing so, blocks the interaction between RANK and RANKL, leading to the inhibition of osteoclast differentiation and activation [47,68].”
Background
The effects of static magnetic fields on bone
Zhang, J., Ding, C., Ren, L. M., Zhou, Y., & Shang, P. (2014) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2014.02.001 · Cited by 117
Mechanisms of bone anabolism regulated by statins
Ruan, F., Zheng, Q., & Wang, J. (2012) · Bioscience Reports · doi:10.1042/bsr20110118 · Cited by 117
Circadian Clock Regulates Bone Resorption in Mice
Xu, C., Ochi, H., Fukuda, T., Sato, S., Sunamura, S., Takarada, T., Hinoi, E., Okawa, A., & Takeda, S. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2803 · Cited by 117
Succinate and its G-protein-coupled receptor stimulates osteoclastogenesis
Guo, Y., Xie, C., Li, X., Yang, J., Yu, T., Zhang, T., Zhang, T., Saxena, D., Snyder, M. P., Wu, Y., et al. (2017) · Nature Communications · doi:10.1038/ncomms15621 · Cited by 119
Human Microvascular Endothelial Cell Activation by IL-1 and TNF-α Stimulates the Adhesion and Transendothelial Migration of Circulating Human CD14+ Monocytes That Develop With RANKL Into Functional Osteoclasts
Kindle, L., Rothe, L., Kriss, M. S., Osdoby, P., & Collin‐Osdoby, P. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.051027 · Cited by 117
The RANKL/OPG system and bone mineral density in patients with chronic liver disease
Moschen, A. R., Kaser, A., Stadlmann, S., Millonig, G., Kaser, S., Mühllechner, P., Habior, A., Graziadei, I. W., Vogel, W., & Tilg, H. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.05.034 · Cited by 119
“c Time between OPG/sRANKL and BMD assessment was 7 (28) [0–112] days detection a mouse anti-human OPG monoclonal antibody (mAb) was purchased from Imgenex (San Diego, CA).”
BackgroundMethod
Generation and culture of osteoclasts
Marino, S., Logan, J. G., Mellis, D. J., & Capulli, M. (2014) · BoneKEy Reports · doi:10.1038/bonekey.2014.65 · Cited by 114
Bio-silica and bio-polyphosphate: applications in biomedicine (bone formation)
Wang, X., Schröder, H. C., Wiens, M., Ushijima, H., & Müller, W. E. G. (2012) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2012.01.018 · Cited by 116
Osteoclast-derived apoptotic bodies couple bone resorption and formation in bone remodeling
Ma, Q., Liang, M., Wu, Y., Luo, F., Ma, Z., Dong, S., Xu, J., & Dou, C. (2021) · Bone Research · doi:10.1038/s41413-020-00121-1 · Cited by 117
Wnt signaling in multiple myeloma: a central player in disease with therapeutic potential
Spaan, I., Raymakers, R. A. P., van de Stolpe, A., & Peperzak, V. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0615-3 · Cited by 114
“They do so by secreting lytic enzymes that degrade the bone matrix [60].”
Background
Microgravity: the immune response and bone
Zayzafoon, M., Meyers, V. E., & McDonald, J. M. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00330.x · Cited by 117
“The processes of osteoblastogenesis and osteoclastogenesis are linked by regulatory cytokines, those released from the matrix during bone resorption by osteoclasts, and receptor activator of nuclear factor-kB ligand and osteoprotegerin by osteoblasts (22).”
Background
Clinical Potential of RANKL Inhibition for the Management of Postmenopausal Osteoporosis and Other Metabolic Bone Diseases
Delmas, P. D. (2008) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2008.02.002 · Cited by 117
Factors involved in the T helper type 1 and type 2 cell commitment and osteoclast regulation in inflammatory apical diseases
Fukada, S. Y., Silva, T. A., Garlet, G. P., Rosa, A. L., Silva, J. S., & Cunha, F. Q. (2008) · Oral Microbiology and Immunology · doi:10.1111/j.1399-302x.2008.00469.x · Cited by 119
“resorption around the tooth apex involves production of direct regulators of osteoclastic activity (RANKL and OPG) and osteoclastic chemotactic factors and receptors (5, 19, 35, 51).”
IL-12 Inhibits Lipopolysaccharide Stimulated Osteoclastogenesis in Mice
Yoshimatsu, M., Kitaura, H., Fujimura, Y., Kohara, H., Morita, Y., & Yoshida, N. (2015) · Journal of Immunology Research · doi:10.1155/2015/214878 · Cited by 114
Effect of denosumab on bone mineral density and biochemical markers of bone turnover: 8-year results of a phase 2 clinical trial
McClung, M. R., Lewiecki, E. M., Geller, M. L., Bolognese, M. A., Peacock, M., Weinstein, R. L., Ding, B., Rockabrand, E., Wagman, R. B., & Miller, P. D. (2012) · Osteoporosis International · doi:10.1007/s00198-012-2052-4 · Cited by 116
“The RANK/ RANK ligand pathway is an important modulator of osteoclast activity [1–6].”
Background
Expression profiling of micro RNA s in RAW 264.7 cells treated with a combination of tumor necrosis factor alpha and RANKL during osteoclast differentiation
Kagiya, T., & Nakamura, S. (2012) · Journal of Periodontal Research · doi:10.1111/jre.12017 · Cited by 113
Overexpression of Smad7 Blocks Primary Tumor Growth and Lung Metastasis Development in Osteosarcoma
Lamora, A., Talbot, J., Bougras-Cartron, G., Amiaud, J., Leduc, M., Chesneau, J., Taurelle, J., Stresing, V., Deley, M. L., Heymann, M., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3191 · Cited by 114
“Here, we clearly demonstrated that Smad7 overexpression in osteosarcoma cells inhibits their ability to produce RANKL or IL11, 2 cytokines that play a central role in bone osteolysis process (40).”
Background
Erythropoietin directly stimulates osteoclast precursors and induces bone loss
Hiram‐Bab, S., Liron, T., Deshet‐Unger, N., Mittelman, M., Gassmann, M., Rauner, M., Franke, K., Wielockx, B., Neumann, D., & Gabet, Y. (2015) · The FASEB Journal · doi:10.1096/fj.14-259085 · Cited by 114
“In bone, osteoclasts are specialized cells derived from monocytes; they adhere to the bone matrix and secrete acid and lytic enzymes to resorb bone (23).”
Background
Integrating GWAS and Co-expression Network Data Identifies Bone Mineral Density Genes SPTBN1 and MARK3 and an Osteoblast Functional Module
Calabrese, G. M., Mesner, L. D., Stains, J. P., Tommasini, S. M., Horowitz, M. C., Rosen, C. J., & Farber, C. R. (2016) · Cell Systems · doi:10.1016/j.cels.2016.10.014 · Cited by 111
“even though bone mass is the net product of formation of bone by the osteoblast and resorption by the osteoclast (Boyle et al., 2003), and several genes implicated by GWAS (particularly at the 34 non-OFM loci), such as TNFSF11 (Yasuda et al.”
Background
Glucocorticoid Regulation of Osteoclast Differentiation and Expression of Receptor Activator of Nuclear Factor-κB (NF-κB) Ligand, Osteoprotegerin, and Receptor Activator of NF-κB in Mouse Calvarial Bones
Swanson, C., Lorentzon, M., Conaway, H. H., & Lerner, U. H. (2006) · Endocrinology · doi:10.1210/en.2005-0717 · Cited by 114
Cells of the Osteoclast Lineage as Mediators of the Anabolic Actions of Parathyroid Hormone in Bone
Koh, A. J., Demiralp, B., Neiva, K. G., Hooten, J. N., Nohutçu, R. M., Shim, H., Datta, N. S., Taichman, R. S., & McCauley, L. K. (2005) · Endocrinology · doi:10.1210/en.2005-0333 · Cited by 114
“The c-src mutant mice have a defect in the signaling that is necessary for osteoclast formation of a ruffled membrane and adherence to the bone substrate (32).”
BackgroundInfluential
Brain-type creatine kinase has a crucial role in osteoclast-mediated bone resorption
Chang, E., Ha, J., Oerlemans, F. T. J. J., Lee, Y. J., Lee, S. W., Ryu, J., Kim, H. J., Lee, Y., Kim, H., Choi, J., et al. (2008) · Nature Medicine · doi:10.1038/nm.1860 · Cited by 114
“1860" language="eng" relation="no"> Osteoclasts differentiate from precursor cells of the monocyte-macrophage lineage and subsequently become activated to be competent for bone resorption through programs primarily governed by receptor activator of nuclear factor-κB ligand in cooperation with macrophage colony–stimula…”
Background
Protective effect of vasoactive intestinal peptide on bone destruction in the collagen-induced arthritis model of rheumatoid arthritis
Juarranz, Y., Abad, C., Martínez, C., Arranz, A., Gutiérrez‐Cañas, I., Rosignoli, F., Gomariz, R. P., & Leceta, J. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1779 · Cited by 114
“A better understanding of the pathogenesis of bone erosion in RA relates to the discovery of osteoclast-mediated bone resorption that is regulated by the receptor activator of nuclear factor-κB (RANK) ligand (RANKL) [2-5,11,12].”
Background
Current concepts in osteolysis
Ollivere, B. J., Wimhurst, J. A., Clark, I. M., & Donell, S. T. (2012) · Journal of Bone and Joint Surgery - British Volume · doi:10.1302/0301-620x.94b1.28047 · Cited by 113
STAT3 controls osteoclast differentiation and bone homeostasis by regulating NFATc1 transcription
Yang, Y., Chung, M., Zhou, S., Gong, X., Xu, H., Hong, Y., Jin, A., Huang, X., Zou, W., Dai, Q., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010139 · Cited by 113
“To test this, we isolated BMMs from 4-week-old WT and Stat3Ctsk mice and cultured them with 20 ng/ml M-CSF and 20 ng/ml RANKL for 7 days.”
BackgroundInfluential
Magnesium and vitamin C supplementation attenuates steroid-associated osteonecrosis in a rat model
Zheng, L.-Z., Wang, J.-L., Xu, J., Zhang, X.-T., Liu, B.-Y., Huang, L., Zhang, R., Zu, H., He, X. M., Mi, J., et al. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119828 · Cited by 115
“, inflammation and oxidative injury could induce osteoclast differentiation [80,81].”
Background
The peripheral cannabinoid receptor knockout mice: an update
Buckley, N. E. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707527 · Cited by 115
“Osteoclasts are derived from cells in the myeloid lineage (Boyle et al., 2003; Xing et al., 2005).”
Background
TNF-related apoptosis-inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSF
Zauli, G., Rimondi, E., Nicolin, V., Melloni, E., Celeghini, C., & Secchiero, P. (2004) · Blood · doi:10.1182/blood-2004-03-1196 · Cited by 115
“(A) Semiquantitative OPG RT-PCR was performed on serial dilutions (1-3) of RNA extracted from cultures treated as indicated.”
Method
Receptor activator of NF-κB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells
Fujisaki, K., Tanabe, N., Suzuki, N., Kawato, T., Takeichi, O., Tsuzukibashi, O., Makimura, M., Ito, K., & Maeno, M. (2007) · Life Sciences · doi:10.1016/j.lfs.2006.12.037 · Cited by 113
The Metabolic Microenvironment Steers Bone Tissue Regeneration
Loeffler, J., Duda, G. N., Sass, F. A., & Dienelt, A. (2018) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2017.11.008 · Cited by 113
Coupling factors involved in preserving bone balance
Kim, B.-J., & Koh, J.-M. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2981-y · Cited by 111
Combination therapeutics in complex diseases
He, B., Lu, C., Zheng, G., He, X., Wang, M., Chen, G., Zhang, G., & Lu, A. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12930 · Cited by 112
“For example, bone homeostasis, the process of creating new bone and removing old bone [11], has been found to be regulated by the WNT protein signalling pathway [12], the Notch signalling pathway [13], the RANK signalling pathway [14] and the bone morphogenetic protein (BMP) signalling pathway [15].”
Background
Migrasomes, a new mode of intercellular communication
Jiang, Y., Liu, X., Ye, J., Ma, Y., Mao, J., Feng, D., & Wang, X. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01121-4 · Cited by 114
“Osteoclasts (OCs), originating from monocytes/macrophages, play a key role in bone development, bone remodeling, and fracture healing [40, 41].”
Background
The Future of Bone Repair: Emerging Technologies and Biomaterials in Bone Regeneration
Łuczak, J. W., Palusińska, M., Matak, D., Pietrzak, D., Nakielski, P., Lewicki, S., Grodzik, M., & Szymański, Ł. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312766 · Cited by 121
P2Y6 Nucleotide Receptors Activate NF-κB and Increase Survival of Osteoclasts
Korčok, J., Raimundo, L., Du, X., Sims, S. M., & Dixon, S. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410764200 · Cited by 112
Comparative effects of five bisphosphonates on apoptosis of macrophage cells in vitro
Moreau, M. F., Guillet, C., Massin, P., Chevalier, S., Gascan, H., Baslé, M. F., & Chappard, D. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.09.031 · Cited by 114
RANKL-Induced Expression of Tetraspanin CD9 in Lipid Raft Membrane Microdomain Is Essential for Cell Fusion During Osteoclastogenesis
Ishii, M., Iwai, K., Koike, M., Ohshima, S., Kudo-Tanaka, E., Ishii, T., Mima, T., Katada, Y., Miyatake, K., Uchiyama, Y., et al. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060308 · Cited by 112
Enamel Matrix Derivative: A Review of Cellular Effects In Vitro and a Model of Molecular Arrangement and Functioning
Grandin, H. M., Gemperli, A. C., & Dard, M. M. (2011) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2011.0365 · Cited by 111
“152 In addition, several studies have reported that ALP acitivity, an indicator for osteoblastic early differentiation, increases upon exposure to EMD.”
Bone Health in Adult Cancer Survivorship
Lustberg, M. B., Reinbolt, R. E., & Shapiro, C. L. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.2097 · Cited by 111
Involvement of acidic microenvironment in the pathophysiology of cancer-associated bone pain
Yoneda, T., Hata, K., Nakanishi, M., Nagae, M., Nagayama, T., Wakabayashi, H., Nishisho, T., Sakurai, T., & Hiraga, T. (2010) · Bone · doi:10.1016/j.bone.2010.07.009 · Cited by 111
“Bone resorption consists of two steps including dissolution of bone minerals and degradation of bone matrix proteins [50,51].”
LIV-1 Promotes Prostate Cancer Epithelial-to-Mesenchymal Transition and Metastasis through HB-EGF Shedding and EGFR-Mediated ERK Signaling
Lue, H.-W., Yang, X., Wang, R., Qian, W., Xu, R. Z. H., Lyles, R. H., Osunkoya, A. O., Zhou, B. P., Vessella, R. L., Zayzafoon, M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027720 · Cited by 112
Combination of IL-6 and sIL-6R differentially regulate varying levels of RANKL-induced osteoclastogenesis through NF-κB, ERK and JNK signaling pathways
Feng, W., Liu, H., Luo, T., Liu, D., Du, J., Sun, J., Wang, W., Han, X., Yang, K., Guo, J., et al. (2017) · Scientific Reports · doi:10.1038/srep41411 · Cited by 121
Immunomodulatory Effects of Dopamine in Inflammatory Diseases
Feng, Y., & Lü, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.663102 · Cited by 113
“Osteoclasts Osteoclasts are tissue-specific macrophage polykaryons that arise from the differentiation of monocyte/macrophage precursor cells at or near the bone surface, whose maturation and activation are mainly related to the activation of the RANK signaling (147).”
Background
Promising bone-related therapeutic targets for rheumatoid arthritis
Choi, Y., Arron, J. R., & Townsend, M. J. (2009) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.175 · Cited by 111
“Osteoclasts differentiate from myeloid lineage precursors under the control of the key pathways involving colony stimulating factor 1 and the RANKL–RANK axis, which act at early and terminal differentiation stages, respectively”
Background
Morphometric, Histomorphometric, and Microcomputed Tomographic Analysis of Periodontal Inflammatory Lesions in a Murine Model
Li, C. H., & Amar, S. (2007) · Journal of Periodontology · doi:10.1902/jop.2007.060320 · Cited by 108
The natural polyamines spermidine and spermine prevent bone loss through preferential disruption of osteoclastic activation in ovariectomized mice
Yamamoto, T. M., Hinoi, E., Fujita, H., Iezaki, T., Takahata, Y., Takamori, M., & Yoneda, Y. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01856.x · Cited by 109
“Osteoclasts are multinucleated cells derived from hematopoietic stem cells shared with macrophage and dendritic cell lineages (Boyle et al., 2003; Teitelbaum and Ross, 2003), while the osteoblast lineage is derived from primitive multipotent mesenchymal stem cells with potential to differentiate…”
Background
Future directions of bone-targeted therapy for metastatic breast cancer
Onishi, T., Hayashi, N., Theriault, R. L., Hortobágyi, G. N., & Ueno, N. T. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.134 · Cited by 110
“Denosumab Denosumab is a fully human monoclonal antibody that specifically targets RANKL, which is one of the principal regulators of osteoclast differentiation, function, and survival”
Background
Expression, signaling, and function of P2X7 receptors in bone
Grol, M. W., Panupinthu, N., Korčok, J., Sims, S. M., & Dixon, S. J. (2009) · Purinergic Signalling · doi:10.1007/s11302-009-9139-1 · Cited by 110
“In this regard, Ca 2+ entry mediated by the P2X7 receptor leads to NFAT activation in microglial-like cells [68] and enhances IL-1β secretion from monocyte and macrophage cell lines [69].”
BackgroundInfluential
HIV‐1 triggers apoptosis in primary osteoblasts and HOBIT cells through TNFα activation
Gibellini, D., Crignis, E. D., Ponti, C., Cimatti, L., Borderi, M., Tschon, M., Giardino, R., & Re, M. C. (2008) · Journal of Medical Virology · doi:10.1002/jmv.21266 · Cited by 110
“bone formation/resorption are tightly linked and coordinated: osteoblasts form new bone whereas osteoclasts degrade the bone matrix to maintain bone homeostasis [Boyle et al., 2003; Kobayashi and Kronenberg, 2005].”
Induction of cytokines, MMP9, TIMPs, RANKL and OPG during orthodontic tooth movement
Grant, M. M., Wilson, J., Rock, P., & Chapple, I. (2012) · European Journal of Orthodontics · doi:10.1093/ejo/cjs057 · Cited by 109
“…Advance Access published September 17, 2012 at U niversity of B irm ingham on Septem ber 18, 2012 http://ejo.oxfordjournals.org/ D ow nloaded from by osteoblastic production of OPG, which serves as a decoy receptor for RANKL, thereby inhibiting osteoclast differentiation (Boyle et al., 2003).”
Background
Regulation of Osteoclast Differentiation and Activity by Lipid Metabolism
Kim, H., Oh, B., & Park‐Min, K. (2021) · Cells · doi:10.3390/cells10010089 · Cited by 113
Osteoclast Precursor Interaction with Bone Matrix Induces Osteoclast Formation Directly by an Interleukin-1-mediated Autocrine Mechanism
Yao, Z., Xing, L., Qin, C., Schwarz, E. M., & Boyce, B. F. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m706415200 · Cited by 111
Recovery Versus Persistence of Disordered Mineral Metabolism in Kidney Transplant Recipients
Evenepoel, P. (2013) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2012.12.019 · Cited by 109
miRNA-based mechanism for the commitment of multipotent progenitors to a single cellular fate
Mann, M., Barad, O., Agami, R., Geiger, B., & Hornstein, E. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0915022107 · Cited by 109
“1, two pivotal transcription factors involved inosteoclast differentiation (4).”
Background
The Alternative Faces of Macrophage Generate Osteoclasts
Lampiasi, N., Russo, R., & Zito, F. (2016) · BioMed Research International · doi:10.1155/2016/9089610 · Cited by 114
“Ultimately, two osteoblast-derived cytokines control osteoclastogenesis, M-CSF, and RANKL [5, 6].”
Background
Bone mesenchymal stem cell secretion of sRANKL/OPG/M-CSF in response to macrophage-mediated inflammatory response influences osteogenesis on nanostructured Ti surfaces
Ma, Q., Fang, L., Jiang, N., Zhang, L., Wang, Y., Zhang, Y., & Chen, L. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.11.003 · Cited by 110
Mature osteoclast–derived apoptotic bodies promote osteogenic differentiation via RANKL-mediated reverse signaling
Ma, Q., Liang, M., Wu, Y., Ding, N., Duan, L., Yu, T., Bai, Y., Kang, F., Dong, S., Xu, J., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.007625 · Cited by 107
Biomaterials and tissue engineering approaches using glycosaminoglycans for tissue repair: Lessons learned from the native extracellular matrix
Menezes, R., Vincent, R., Osorno, L., Hu, P., & Arinzeh, T. L. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.09.064 · Cited by 121
IL-7 Up-Regulates TNF-α-Dependent Osteoclastogenesis in Patients Affected by Solid Tumor
Roato, I., Brunetti, G., Gorassini, E., Grano, M., Colucci, S., Bonello, L., Buffoni, L., Manfredi, R., Ruffini, E., Ottaviani, D., et al. (2006) · PLoS ONE · doi:10.1371/journal.pone.0000124 · Cited by 125
“The OCs derive from cells of the monocytic-macrophagic lineage, which fuse to form bone-resorbing cells in the presence of Macrophage Colony Stimulating Factor (M-CSF) and Receptor Activator of Nuclear factor kB Ligand (RANKL) [13] or Tumor Necrosis Factora (TNF-a) [14,15].”
Background
Molecular mechanisms of inflammatory bone damage: emerging targets for therapy
Herman, S., Krönke, G., & Schett, G. A. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.04.001 · Cited by 110
Taking a Toll on the bones: Regulation of bone metabolism by innate immune regulators
Bar‐Shavit, Z. (2008) · Autoimmunity · doi:10.1080/08916930701694469 · Cited by 110
“Although a variety of hormones and cytokines are involved in the development of the multinucleated OC, it seems that the most important osteoclastogenic factor is the receptor activator of NF-kB (RANK) ligand (RANKL), a member of the TNF family [11,12].”
Background
Hormonal contraception and bone metabolism: a systematic review
Nappi, C., Bifulco, G., Tommaselli, G. A., Gargano, V., & Carlo, C. D. (2012) · Contraception · doi:10.1016/j.contraception.2012.04.009 · Cited by 110
Current research in the pathogenesis of aseptic implant loosening associated with particulate wear debris.
Jiang, Y., Jia, T., Wooley, P. H., & Yang, S. (2013) · PubMed · Cited by 107
Angiogenesis is uncoupled from osteogenesis during calvarial bone regeneration
Bixel, M. G., Sivaraj, K. K., Timmen, M., Mohanakrishnan, V., Aravamudhan, A., Adams, S., Koh, B. I., Jeong, H., Kruse, K., Stange, R., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48579-5 · Cited by 121
“Osteoclasts are critical for the resorption of calci ﬁ ed bone and play a signi ﬁ cant role in bone remodeling during fracture healing 51,52 .”
Bisphosphonates: effects on osteoblast
Maruotti, N., Corrado, A., Neve, A., & Cantatore, F. P. (2012) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-012-1216-7 · Cited by 106
“On the other hand, osteoblasts are also involved in osteoprotegerin (OPG) production, a soluble decoy receptor for RANKL, which competitively inhibits the binding of RANKL to RANK on the cell membrane of osteoclasts, thus impeding RANK activation and the subsequent osteoclast activation [26].”
BackgroundInfluential
Regulation of RANKL‐induced osteoclastogenesis by TGF‐β through molecular interaction between Smad3 and Traf6
Yasui, T., Kadono, Y., Nakamura, M., Oshima, Y., Matsumoto, T., Masuda, H., Hirose, J., Omata, Y., Yasuda, H., Imamura, T., et al. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.357 · Cited by 114
BMD and Body Composition in Children and Young Patients Affected by Cystic Fibrosis
Bianchi, M. L., Romano, G., Saraifoger, S., Costantini, D., Limonta, C., & Colombo, C. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.051106 · Cited by 107
Lineage-committed osteoclast precursors circulate in blood and settle down into bone
Muto, A., Mizoguchi, T., Udagawa, N., Ito, S., Kawahara, I., Abiko, Y., Arai, A., Harada, S., Kobayashi, Y., Nakamichi, Y., et al. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.490 · Cited by 109
RETRACTED: Graphene‐Based MicroRNA Transfection Blocks Preosteoclast Fusion to Increase Bone Formation and Vascularization
Dou, C., Ding, N., Luo, F., Hou, T., Cao, Z., Bai, Y., Liu, C., Xu, J., & Dong, S. (2017) · Advanced Science · doi:10.1002/advs.201700578 · Cited by 105
Retracted
The cellular and molecular mechanisms of bone invasion by oral squamous cell carcinoma
Jimi, E., Furuta, H., Matsuo, K., Tominaga, K., Takahashi, T., & Nakanishi, O. (2010) · Oral Diseases · doi:10.1111/j.1601-0825.2010.01781.x · Cited by 105
“Furthermore, mice lacking RANK have a complete block of osteoclast development that can be rescued by the transplantation of bone marrow cells from wild-type mice, indicating that RANK-deficient mice have an intrinsic defect in osteoclast function (Nakashima et al, 2003; Boyle et al, 2003).”
Background
A 3D in vitro bone organ model using human progenitor cells
Papadimitropoulos, A., Scherberich, A., Güven, S., Theilgaard, N., Crooijmans, H., Santini, F., Scheffler, K., Zallone, A. Z., & Martín, I. (2011) · European Cells and Materials · doi:10.22203/ecm.v021a33 · Cited by 107
Siglec-15 Protein Regulates Formation of Functional Osteoclasts in Concert with DNAX-activating Protein of 12 kDa (DAP12)
Ishida‐Kitagawa, N., Tanaka, K., Bao, X., Kimura, T., Miura, T., Kitaoka, Y., Hayashi, K., Sato, M., Maruoka, M., Ogawa, T., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.324194 · Cited by 106
The Tec Family Tyrosine Kinase Btk Regulates RANKL-induced Osteoclast Maturation
Lee, S. H., Kim, T. S., Jeong, D., Kim, N., & Choi, Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708935200 · Cited by 106
Selective inhibition of RANK blocks osteoclast maturation and function and prevents bone loss in mice
Kim, H., Choi, H. K., Shin, J. H., Kim, K., Huh, J. Y., Lee, S. A., Ko, C., Kim, H.-S., Shin, H.-I., Jeong, D., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36809 · Cited by 106
Pathogenesis of psoriatic arthritis
Anandarajah, A., & Ritchlin, C. T. (2004) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000129718.13939.81 · Cited by 105

Authors: Boyle, W. J., Simonet, W. S., & Lacey, D. L.
Affiliations: Amgen (United States) (US)
Corresponding author: Boyle, William J.
ORCID: Boyle, William J.
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2003-05
Volume: 423
Issue: 6937
Pages: 337-342
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature01658
OpenAlex: W2093252878
Cited by: 6,670
References: 77
Citations by year: 2026: 240 · 2025: 269 · 2024: 294 · 2023: 357 · 2022: 349 · 2021: 404 · 2020: 376 · 2019: 381 · 2018: 371 · 2017: 324 · 2016: 311 · 2015: 332 · 2014: 352 · 2013: 315 · 2012: 336
FWCI: 11.72
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Bone and Dental Protein Studies
Keywords: osteoclasts, osteoclastogenesis, bone resorption, monocyte/macrophage lineage, bone matrix degradation, hormonal regulation of bone, osteoporosis
MeSH terms: Animals, Bone Resorption, Carrier Proteins, Cell Differentiation, Glycoproteins, Humans, Membrane Glycoproteins, Osteoclasts, Osteoporosis, Signal Transduction, Receptors, Tumor Necrosis Factor, Receptors, Cytoplasmic and Nuclear, Osteoprotegerin, RANK Ligand, Receptor Activator of Nuclear Factor-kappa B

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Osteoclast differentiation and activation

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks